---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-06-17T20:43:48.337807'
end_time: '2026-06-17T20:50:29.574052'
duration_seconds: 401.24
template_file: /Users/marcin/Documents/VIMSS/ontology/KG-Hub/KG-Microbe/TraitMech/templates/trait_causal_graph_research.md
template_variables:
  trait_label: pathogenic to host
  trait_identifier: METPO:1004000
  trait_category: ECOLOGY
  trait_category_slug: ecology
  trait_slug: pathogenic_to_host
  term_kind: CLASS
  mapping_status: REVIEWED
  definition: A phenotype where a microbe is a pathogen of some host organism.
  parent_traits: METPO:1000059
  synonyms: General.keywords, Safety information.risk assessment
  evidence_summary: 'DOI:10.1146/annurev.micro.62.081307.162938: virulence factors
    (Virulence-factor review supports the encoding of dedicated virulence factors
    as the molecular basis of host pathogenicity.) | DOI:10.1038/nrmicro1592: secretion
    systems (Secretion-systems review supports protein secretion machineries as central
    effectors of host pathogenicity across kingdoms.)'
  causal_graph_summary: 'pathogenic_to_host_virulence_factor_program: 5 nodes, 4 edges'
provider_config:
  timeout: null
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 35
---

## Question

# Microbial Trait Causal Graph Research Template

## Target Trait
- **Trait label:** pathogenic to host
- **METPO identifier:** METPO:1004000
- **Trait category:** ECOLOGY
- **Term kind:** CLASS
- **Mapping status:** REVIEWED
- **Definition:** A phenotype where a microbe is a pathogen of some host organism.
- **Parent traits:** METPO:1000059
- **Synonyms:** General.keywords, Safety information.risk assessment
- **Existing evidence:** DOI:10.1146/annurev.micro.62.081307.162938: virulence factors (Virulence-factor review supports the encoding of dedicated virulence factors as the molecular basis of host pathogenicity.) | DOI:10.1038/nrmicro1592: secretion systems (Secretion-systems review supports protein secretion machineries as central effectors of host pathogenicity across kingdoms.)
- **Existing causal graph summary:** pathogenic_to_host_virulence_factor_program: 5 nodes, 4 edges

## Research Objective

Research the microbial trait **pathogenic to host** as a candidate TraitMech causal graph.
Focus on source-backed mechanistic entities and causal edges that can be curated into
`data/traits/ecology/pathogenic_to_host.yaml`.

## Required Findings

### 1. Trait Scope
- Clarify what phenotype, physiological capacity, environmental preference, or assay-observed
  property the trait represents.
- Identify boundary cases and distinguish the trait from nearby traits.

### 2. Causal Graph Entities
- Pathways and metabolic modules.
- Environmental factors and experimental factors.
- Genes, proteins, enzymes, transporters, and complexes.
- Chemicals, electron donors, electron acceptors, nutrients, metabolites, and inhibitors.
- Organelles, cellular localizations, molecular functions, and biological processes.

### 3. Evidence-Backed Edges
- Propose causal edges as subject-predicate-object triples.
- For every proposed edge, provide a reference, a short supporting quote/snippet, and notes
  explaining how the source supports the edge.
- Prefer DOI references. Use PMID only when a DOI is not available.
- Mark weak, taxon-specific, assay-specific, or inferred claims as uncertain.

### 4. Ontology Grounding
- Suggest CURIEs where available: METPO, GO, CHEBI, ENVO, NCBITaxon, EC, UniProt, Rhea,
  KEGG, MetaCyc, or other stable identifiers.
- Do not invent identifiers. Label-only candidate nodes are acceptable when grounding is unclear.

## Output Format

Return a curation-focused report with:
- A short scope summary.
- Candidate nodes grouped by type.
- Candidate causal edges in a table with reference, snippet, and notes.
- DOI-first bibliography.
- Warnings for claims that should not yet be curated into TraitMech.


## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Microbial Trait Causal Graph Research Template

## Target Trait
- **Trait label:** pathogenic to host
- **METPO identifier:** METPO:1004000
- **Trait category:** ECOLOGY
- **Term kind:** CLASS
- **Mapping status:** REVIEWED
- **Definition:** A phenotype where a microbe is a pathogen of some host organism.
- **Parent traits:** METPO:1000059
- **Synonyms:** General.keywords, Safety information.risk assessment
- **Existing evidence:** DOI:10.1146/annurev.micro.62.081307.162938: virulence factors (Virulence-factor review supports the encoding of dedicated virulence factors as the molecular basis of host pathogenicity.) | DOI:10.1038/nrmicro1592: secretion systems (Secretion-systems review supports protein secretion machineries as central effectors of host pathogenicity across kingdoms.)
- **Existing causal graph summary:** pathogenic_to_host_virulence_factor_program: 5 nodes, 4 edges

## Research Objective

Research the microbial trait **pathogenic to host** as a candidate TraitMech causal graph.
Focus on source-backed mechanistic entities and causal edges that can be curated into
`data/traits/ecology/pathogenic_to_host.yaml`.

## Required Findings

### 1. Trait Scope
- Clarify what phenotype, physiological capacity, environmental preference, or assay-observed
  property the trait represents.
- Identify boundary cases and distinguish the trait from nearby traits.

### 2. Causal Graph Entities
- Pathways and metabolic modules.
- Environmental factors and experimental factors.
- Genes, proteins, enzymes, transporters, and complexes.
- Chemicals, electron donors, electron acceptors, nutrients, metabolites, and inhibitors.
- Organelles, cellular localizations, molecular functions, and biological processes.

### 3. Evidence-Backed Edges
- Propose causal edges as subject-predicate-object triples.
- For every proposed edge, provide a reference, a short supporting quote/snippet, and notes
  explaining how the source supports the edge.
- Prefer DOI references. Use PMID only when a DOI is not available.
- Mark weak, taxon-specific, assay-specific, or inferred claims as uncertain.

### 4. Ontology Grounding
- Suggest CURIEs where available: METPO, GO, CHEBI, ENVO, NCBITaxon, EC, UniProt, Rhea,
  KEGG, MetaCyc, or other stable identifiers.
- Do not invent identifiers. Label-only candidate nodes are acceptable when grounding is unclear.

## Output Format

Return a curation-focused report with:
- A short scope summary.
- Candidate nodes grouped by type.
- Candidate causal edges in a table with reference, snippet, and notes.
- DOI-first bibliography.
- Warnings for claims that should not yet be curated into TraitMech.


# Curation-Focused Research Report: **pathogenic to host** (METPO:1004000)

## 1) Scope summary (TraitMech curation view)
The METPO trait **“pathogenic to host”** refers to a microbial phenotype where an organism (often at the strain level) can **colonize and/or invade a host** and **cause host damage or dysfunction**, typically via **dedicated virulence programs** (adhesion/invasion determinants, secretion systems and effectors/toxins, immune evasion, and persistence strategies such as biofilms). Modern framing emphasizes that “pathogenicity” is not purely intrinsic; it is **context dependent** on host species, host immune status, and the microbe’s ability to acquire or tune virulence determinants through **horizontal gene transfer (HGT), recombination, and small adaptive mutations** that shift host tropism or immune evasion capacity. Evidence for host-range shifts driven by small sequence changes in adhesins/surface proteins and by HGT is highlighted in recent synthesis work on host adaptation. (barber2024mechanismsofhost pages 1-2, barber2024mechanismsofhost pages 8-10)

### Boundary cases / distinctions (what NOT to conflate)
* **Colonization without damage** (commensalism) vs **pathogenicity**: many microbes colonize hosts but are not pathogenic unless they encode/express virulence programs that damage tissues or subvert immunity.
* **Opportunistic pathogenicity**: commensals can become opportunistic pathogens when they acquire new virulence modules or when host context changes; recent work shows a gut commensal lineage diversifying toward pathogenicity via acquisition of an additional T3SS (a mechanistic boundary-case between commensal and pathogen). (klein2024pathogenicdiversificationof pages 1-2)
* **Toxicity vs pathogenicity**: toxin production can be sufficient for host damage, but the trait “pathogenic to host” is broader and typically includes colonization/invasion, immune evasion, and persistence mechanisms. (pandey2024bacterialpathogenesis pages 8-10)

## 2) Key concepts and definitions (current understanding)
### 2.1 Virulence factors and virulence programs
Pathogenicity is often mediated by **virulence factors** that enable: (i) **attachment and invasion**, (ii) **delivery of effectors** (e.g., via Type III secretion), (iii) **toxin-mediated damage**, and (iv) **immune evasion** (e.g., complement antagonism, antibody interference). (pandey2024bacterialpathogenesis pages 17-19, barber2024mechanismsofhost pages 8-10)

### 2.2 Host adaptation as a genetic mechanism of pathogenicity
Host pathogenicity can be gained or altered via:
* **Point mutations** in adhesins/surface proteins that change host receptor binding and enable invasion/colonization in a new host. (barber2024mechanismsofhost pages 1-2)
* **HGT/recombination/gene gain–loss**, enabling acquisition or deletion of virulence modules and changes in host range. (barber2024mechanismsofhost pages 1-2, klein2024pathogenicdiversificationof pages 1-2)

### 2.3 Biofilm-mediated pathogenicity and quorum sensing (QS)
Biofilms are structured microbial communities embedded in an extracellular matrix; they contribute to pathogenicity by **immune evasion** and **marked antibiotic tolerance/resistance**. QS is a density-dependent signaling system (autoinducers) that can **globally regulate virulence genes** and drive **biofilm formation/maturation**. (d’aquila2024quorumquenchingapproaches pages 1-2, juszczukkubiak2024molecularaspectsof pages 2-3, mitra2024combattingbiofilmmediatedinfections pages 1-2)

## 3) Candidate mechanistic nodes (grouped by type; ontology grounding when available)

### A. Microbial systems / pathways
* **Type III secretion system (T3SS)** (GO:0030257 protein secretion by the type III secretion system; label-only for specific families) (pandey2024bacterialpathogenesis pages 17-19, wale2024amasterregulator pages 1-2)
* **Quorum sensing (QS)** (label-only; regulatory system) (juszczukkubiak2024molecularaspectsof pages 2-3, mitra2024combattingbiofilmmediatedinfections pages 1-2)
* **Biofilm formation / biofilm matrix (EPS)** (label-only; community phenotype/structure) (d’aquila2024quorumquenchingapproaches pages 1-2, erkihun2024medicalscopeof pages 1-2)
* **Complement evasion mechanisms** (label-only; includes factor H/C4BP recruitment, C3 convertase inhibition) (barber2024mechanismsofhost pages 8-10)

### B. Genes / proteins (examples strongly supported but often taxon-specific)
* Adhesins/surface proteins: **FimH** (label-only), **InlA** (label-only) (barber2024mechanismsofhost pages 1-2)
* T3SS regulators: **PdhR** (label-only), **LEE** pathogenicity island (label-only) (wale2024amasterregulator pages 1-2)
* Immune evasion factors (examples): **CHIPS**, **SCIN**, **SpA** (label-only) (barber2024mechanismsofhost pages 8-10)
* QS regulators (Pseudomonas example): **LasR/LasI**, **RhlR/RhlI**; virulence targets **lasB**, **toxA**, **lecA** (label-only) (juszczukkubiak2024molecularaspectsof pages 2-3)

### C. Chemicals / metabolites
* **Pyruvate** (CHEBI:15361) as a metabolic signal influencing virulence regulation via PdhR in attaching/effacing pathogens. (wale2024amasterregulator pages 1-2)
* **Autoinducers**: **AHLs** (label-only) and other QS signals (AI-2, peptides; label-only in this evidence set). (juszczukkubiak2024molecularaspectsof pages 2-3, erkihun2024medicalscopeof pages 1-2)

### D. Mobile genetic elements / evolutionary entities
* **Plasmids** (label-only) carrying virulence modules such as T3SS. (klein2024pathogenicdiversificationof pages 1-2)
* **Accessory genome/genomic islands** (label-only) as reservoirs for virulence determinants and horizontal transfer. (valik2024genomicvirulencemarkers pages 1-2)

## 4) Candidate causal edges (evidence-backed triples)
The following artifact compiles candidate edges with supporting snippets, DOI-first references, suggested grounding, and curation notes.

| Edge (subject–predicate–object) | Node type(s) | Suggested ontology grounding | Evidence snippet | Reference (DOI, year, URL) | Curation notes / uncertainty |
|---|---|---|---|---|---|
| FimH adhesin variant → increases affinity for host receptor → host colonization/invasion | protein → host target/process | FimH (label-only); GO:0044406 host cell adhesion; METPO:1004000 | “nucleotide changes in the fimH adhesin” were linked to host-specific adaptation; very few mutations can shift host tropism (barber2024mechanismsofhost pages 1-2) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Strong concept-level support for adhesin sequence variation driving pathogenic host adaptation, but taxon-specific examples; curate as generalizable with note. |
| InlA amino-acid substitutions → increase binding to E-cadherin → host cell invasion | protein → host receptor → process | InlA (label-only); E-cadherin/CDH1 (label-only); GO:0046718 viral entry into host cell analog not appropriate; use GO:0044409 entry into host | “two substitutions in Listeria monocytogenes InlA increasing affinity for murine E-cadherin and enabling host cell invasion” (barber2024mechanismsofhost pages 1-2) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Strong but species-specific; useful canonical edge for adhesin/receptor binding. |
| Type III secretion system → delivers effector proteins into host cells → manipulation of host signaling/cytoskeleton/immune responses | secretion system complex → biological process | GO:0030257 protein secretion by the type III secretion system; GO:0050794 regulation of cellular process; METPO:1004000 | “a conduit for the passage of effector proteins”; effectors “manipulating various cellular processes” including “subversion of host cell signaling pathways, alteration of the cytoskeleton ... and modulation of immune responses” (pandey2024bacterialpathogenesis pages 17-19) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Broad mechanistic edge central to pathogenicity; source is a book chapter, so keep as medium-confidence general background. |
| LEE-encoded T3SS → enables intimate attachment to colonic epithelium → host colonization | pathogenicity island / secretion system → phenotype | LEE (label-only); GO:0030257; GO:0044406; METPO:1004000 | “type 3 secretion system used to intimately attach to the colonic epithelium. This crucial virulence factor is encoded on a pathogenicity island known as the Locus of Enterocyte Effacement” (wale2024amasterregulator pages 1-2) | 10.1371/journal.ppat.1012451, 2024, https://doi.org/10.1371/journal.ppat.1012451 | Strong in attaching/effacing pathogens; may be too clade-specific for a generic node unless tagged taxon-specific. |
| PdhR → directly activates LEE master regulatory region → increased T3SS expression | transcription factor → regulatory DNA / process | PdhR (label-only); LEE (label-only); GO:0006355 regulation of DNA-templated transcription; GO:0030257 | “PdhR directly binds to a specific motif within the LEE master regulatory region, thus activating type 3 secretion directly” (wale2024amasterregulator pages 1-2) | 10.1371/journal.ppat.1012451, 2024, https://doi.org/10.1371/journal.ppat.1012451 | Strong, recent primary evidence; taxon-specific but high value for metabolism→virulence regulation edge. |
| Cellular pyruvate / central carbon metabolism state → modulates PdhR activity → virulence gene expression | metabolite/process → regulator → process | CHEBI:15361 pyruvate; PdhR (label-only); GO:0006099 tricarboxylic acid cycle/cellular metabolic process; GO:0006355 | PdhR is “traditionally known as a regulator of central metabolism in response to cellular pyruvate levels” and is a “key activator of the LEE” (wale2024amasterregulator pages 1-2) | 10.1371/journal.ppat.1012451, 2024, https://doi.org/10.1371/journal.ppat.1012451 | Indirect but mechanistically meaningful edge linking metabolic state to pathogenicity; inferred from regulatory logic, moderate confidence. |
| Acquisition of plasmid-encoded T3SS1a → promotes entry into epithelial cells → intracellular pathogenicity | mobile genetic element / secretion system → process | plasmid (GO/Sequence Ontology label-only); T3SS1a (label-only); GO:0044409 entry into host; METPO:1004000 | “T3SS1a is plasmid-encoded” and required for “entry, vacuole lysis, and cytosolic proliferation” especially in intestinal epithelial cells (klein2024pathogenicdiversificationof pages 1-2) | 10.1128/iai.00314-24, 2024, https://doi.org/10.1128/iai.00314-24 | Strong primary evidence; host-cell-type specific and species-specific. |
| T3SS1a → promotes vacuole lysis and cytosolic proliferation → increased virulence | secretion system → process → phenotype | T3SS1a (label-only); vacuole lysis (label-only); GO:0044409; METPO:1004000 | “The requirement for T3SS1a in entry, vacuole lysis, and cytosolic replication is host cell type-specific” (klein2024pathogenicdiversificationof pages 1-2) | 10.1128/iai.00314-24, 2024, https://doi.org/10.1128/iai.00314-24 | Strong but species-specific; curate as uncertain/generalized outside Providencia. |
| Acquisition of a second T3SS → broadens host range → pathogenic diversification | mobile genetic element / secretion system → ecology trait | T3SS1a/T3SS1b (label-only); host range (label-only); METPO:1004000 | “acquisition of two T3SS has allowed P. alcalifaciens to diversify its host range” (klein2024pathogenicdiversificationof pages 1-2) | 10.1128/iai.00314-24, 2024, https://doi.org/10.1128/iai.00314-24 | Useful HGT→virulence trait edge; specific to Providencia but conceptually important. |
| Horizontal gene transfer / recombination / gene gain-loss → drives acquisition of virulence-associated host adaptation traits → pathogenicity | evolutionary process → phenotype | GO:0016567 protein ubiquitination not relevant; use label-only for HGT/recombination; METPO:1004000 | “horizontal gene transfer ... gene acquisition and deletion, and genome rearrangements” are “major drivers of host adaptation” (barber2024mechanismsofhost pages 1-2) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | High-level edge supported by review; not a single molecular mechanism, but important graph edge for evolutionary acquisition. |
| Accessory/mobile gene pool → carries virulence factors and resistance determinants → severe pathogenic phenotypes | genomic region → phenotype | pathogenicity island/genomic island/accessory genome (label-only); METPO:1004000 | “accessory gene pool with elements that can be horizontally transferred” carries virulence factors including T3SS-associated exotoxins (valik2024genomicvirulencemarkers pages 1-2) | 10.1038/s43856-024-00696-4, 2024, https://doi.org/10.1038/s43856-024-00696-4 | Strong for Pseudomonas bloodstream isolates; may be too broad unless represented as accessory genome node. |
| Protective antigen (PA) → mediates entry of edema factor and lethal factor into host cells → anthrax toxin activity/pathogenicity | toxin component / transport function | PA (label-only); EF (label-only); LF (label-only); GO:0046718 not ideal; label-only toxin entry | “protective antigen (PA) mediates entry of edema factor (EF) and lethal factor (LF) into host cells” (pandey2024bacterialpathogenesis pages 8-10) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Canonical toxin mechanism; species-specific but strong. |
| Edema factor → causes edema → host tissue damage | toxin → phenotype | Edema factor (label-only); host tissue damage (label-only) | “EF causing edema” (pandey2024bacterialpathogenesis pages 8-10) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Direct toxin-action edge; taxon-specific. |
| Lethal factor → induces host cell death → virulence | toxin → process | Lethal factor (label-only); GO:0012501 programmed cell death | “LF inducing cell death” (pandey2024bacterialpathogenesis pages 8-10) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Direct toxin-action edge; taxon-specific. |
| Diphtheria toxin → inhibits eukaryotic protein synthesis via ADP-ribosylation of EF-2 → host damage | toxin → molecular function/process | diphtheria toxin (label-only); elongation factor 2 (label-only) | “diphtheria toxin ... inhibits eukaryotic protein synthesis via ADP-ribosylation of elongation factor 2” (pandey2024bacterialpathogenesis pages 8-10) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Strong classic toxin edge; species-specific. |
| TcdA/TcdB toxins → damage colonic epithelium → inflammation and diarrhea | toxins → tissue/process | TcdA (label-only); TcdB (label-only); colon epithelium (UBERON label-only) | “toxin A (TcdA) and toxin B (TcdB) drive pathogenicity” and “damage the colonic epithelium causing inflammation and diarrhea” (pandey2024bacterialpathogenesis pages 8-10) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Good canonical toxin-mediated pathogenicity edge. |
| Antiphagocytic capsule → resists phagocytosis → immune evasion/pathogenicity | cellular structure → process | capsule (label-only); GO:0006909 phagocytosis; GO:0050776 regulation of immune response | “an antiphagocytic capsule aids immune evasion” (pandey2024bacterialpathogenesis pages 8-10) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Strong generic capsule→phagocytosis edge, though example from Bacillus anthracis. |
| Polysaccharide capsule → resists phagocytosis → increased virulence | cellular structure → process | capsule (label-only); GO:0006909 | “Klebsiella pneumoniae employs a polysaccharide capsule to resist phagocytosis” (pandey2024bacterialpathogenesis pages 10-13) | 10.58532/nbennurmmch1, 2024, https://doi.org/10.58532/nbennurmmch1 | Redundant with previous capsule edge but from distinct taxon; supports generalization. |
| CspA / surface proteins → bind complement factor H or C4BP → complement evasion | protein → host protein → process | CspA (label-only); complement factor H (label-only); C4BP (label-only); GO:0060337 type I interferon signaling not relevant; label-only complement evasion | “binding factor H and C4BP” and evolution of surface proteins “to evade complement” (barber2024mechanismsofhost pages 8-10) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Strong mechanism from review; taxon-specific examples but broadly generalizable to complement regulator recruitment. |
| CHIPS → antagonizes C5a and formylated peptide receptors → disrupted chemotaxis/immune evasion | secreted protein → host receptor/process | CHIPS (label-only); C5a receptor/C5AR1 (label-only); formyl peptide receptor/FPR1 (label-only) | “CHIPS binds C5a and formylated peptide receptors to disrupt chemotaxis” (barber2024mechanismsofhost pages 8-10) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Strong but highly taxon-specific (S. aureus); curate as uncertain for universal graph. |
| SCIN → binds C3 convertase → prevents complement activation | secreted protein → host complex/process | SCIN (label-only); C3 convertase (label-only); complement activation (label-only) | “SCIN binds the C3 convertase to prevent activation” (barber2024mechanismsofhost pages 8-10) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Strong but taxon-specific. |
| IgA protease → cleaves host IgA → immune evasion | protease → host immunoglobulin | IgA protease (label-only); IgA (label-only) | “proteases that cleave IgA” are noted as humoral immunity countermeasures (barber2024mechanismsofhost pages 8-10) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Broadly useful edge, but exact proteins vary by taxon; keep generic. |
| Staphylococcal protein A (SpA) → binds IgG → blocks opsonization and phagocytosis | protein → host immunoglobulin/process | SpA (label-only); IgG (label-only); GO:0006911 phagocytosis, engulfment | “IgG-binding proteins like staphylococcal protein A (SpA) ... block opsonization and phagocytosis” (barber2024mechanismsofhost pages 8-10) | 10.1093/femsre/fuae019, 2024, https://doi.org/10.1093/femsre/fuae019 | Strong immune-evasion edge; taxon-specific example but generic mechanism. |
| Quorum sensing autoinducers → activate global virulence gene expression → pathogenicity | signaling chemical / regulatory system → process | autoinducer (label-only); quorum sensing (label-only); GO:0006355; METPO:1004000 | AIs are “hormone-like molecules” that trigger sensor proteins to “mediate changes in global gene expression”; QS controls “virulence factor production” (juszczukkubiak2024molecularaspectsof pages 2-3) | 10.3390/ijms25052655, 2024, https://doi.org/10.3390/ijms25052655 | Strong general edge for QS→virulence. |
| LasR/LasI and RhlR/RhlI quorum sensing systems → upregulate elastase/exotoxin A/rhamnolipids/pyocyanin/lectins → virulence | regulatory proteins/system → virulence factors | LasR/LasI/RhlR/RhlI (label-only); lasB/toxA/lecA (label-only) | “LasR/LasI and RhlR/RhlI QS systems are ... key expression regulators of many virulence factors, including elastase (lasB)... exotoxin A (toxA)... pyocyanin... and lectins (lecA)” (juszczukkubiak2024molecularaspectsof pages 2-3) | 10.3390/ijms25052655, 2024, https://doi.org/10.3390/ijms25052655 | Strong but Pseudomonas-specific; good detailed subgraph candidate. |
| Quorum sensing → stimulates exopolysaccharide synthesis → biofilm maturation | regulatory system → process/structure | quorum sensing (label-only); EPS/exopolysaccharide (label-only); biofilm (label-only) | QS-dependent genes “produce exopolysaccharides that contribute directly to mature biofilm architecture” (d’aquila2024quorumquenchingapproaches pages 1-2) | 10.3390/antibiotics13070619, 2024, https://doi.org/10.3390/antibiotics13070619 | Strong generalizable edge. |
| Quorum sensing → promotes biofilm formation and maintenance → persistent infection | regulatory system → community phenotype | quorum sensing (label-only); biofilm (label-only); METPO:1004000 | QS is “crucial for biofilm formation and maintenance” (mitra2024combattingbiofilmmediatedinfections pages 1-2) | 10.1016/j.tcsw.2024.100133, 2024, https://doi.org/10.1016/j.tcsw.2024.100133 | Strong high-level edge; clinically relevant. |
| Biofilm extracellular matrix → limits antimicrobial penetration / protects deeper cells → antibiotic tolerance | community structure → process | biofilm; EPS matrix (label-only) | “EPS matrix protects deeper-layer cells from antimicrobials” (erkihun2024medicalscopeof pages 1-2); biofilm bacteria increase resistance “about 1000 fold” (juszczukkubiak2024molecularaspectsof pages 2-3) | 10.3390/bacteria3030008, 2024, https://doi.org/10.3390/bacteria3030008; 10.3390/ijms25052655, 2024, https://doi.org/10.3390/ijms25052655 | Strong and quantitatively supported; broad generalization justified. |
| Biofilm → evades host immune response → chronic/persistent infection | community phenotype → process | biofilm (label-only); immune evasion (label-only) | “Biofilms ... help bacteria evade the immune response” (d’aquila2024quorumquenchingapproaches pages 1-2) | 10.3390/antibiotics13070619, 2024, https://doi.org/10.3390/antibiotics13070619 | Strong concept-level edge. |
| Biofilm-related genes → associated with severe clinical outcome → mortality/septic complications | genes/process → clinical phenotype | biofilm synthesis genes (label-only) | “Genes tied to biofilm synthesis” were associated with mortality in P. aeruginosa bloodstream infection (valik2024genomicvirulencemarkers pages 1-2) | 10.1038/s43856-024-00696-4, 2024, https://doi.org/10.1038/s43856-024-00696-4 | Association in human cohort, not direct causation; mark uncertain for TraitMech causal curation. |
| Type III secretion system → associated with septic shock → severe host disease | secretion system → clinical phenotype | GO:0030257; septic shock (label-only) | “type III secretion system is associated with septic shock” (valik2024genomicvirulencemarkers pages 1-2) | 10.1038/s43856-024-00696-4, 2024, https://doi.org/10.1038/s43856-024-00696-4 | Human clinical association, not direct experiment; useful but should be flagged as outcome-association edge. |
| AHL quorum signals → increase antibiotic tolerance → persistence | chemical signal → phenotype | AHL/acyl-homoserine lactone (label-only) | “AHL-driven increases in antibiotic tolerance” including higher resistance to ciprofloxacin and carbenicillin in P. aeruginosa (naga2024aninsighton pages 1-4) | 10.1007/s10096-024-04920-w, 2024, https://doi.org/10.1007/s10096-024-04920-w | Useful but somewhat species/assay specific; mark uncertain if generalized. |
| Quorum-quenching enzymes / QS inhibitors → disrupt quorum sensing → reduced biofilm and pathogenicity | enzyme/small molecule → regulatory system/process | quorum quenching enzyme (label-only); quorum sensing inhibitor (label-only) | “QQEs/QSIs reduce pathogenicity and biofilm synthesis” and can be used in “dressings and catheters” (naga2024aninsighton pages 1-4) | 10.1007/s10096-024-04920-w, 2024, https://doi.org/10.1007/s10096-024-04920-w | Intervention edge, useful for applications; not intrinsic trait mechanism but relevant for assay/perturbation nodes. |


*Table: This table compiles candidate causal edges for the trait 'pathogenic to host' with evidence snippets, ontology suggestions, and curation notes. It is designed to help prioritize which mechanisms are strong enough for TraitMech curation and which should remain taxon- or assay-qualified.*

## 5) Recent developments and latest research (prioritizing 2023–2024)

### 5.1 Metabolism–virulence coupling (2024)
A 2024 study in *PLOS Pathogens* provides a clear mechanistic example that **core metabolic regulation can directly activate virulence gene expression**: the transcription factor **PdhR** (responsive to cellular **pyruvate**) directly binds a motif in the **LEE** master regulatory region, activating **type III secretion** and enhancing host-cell adhesion; PdhR was also required for effective host colonization in vivo in a murine model system. This supports adding “metabolic state → transcriptional regulator → secretion system expression” edges as curatable mechanistic links. **Publication date:** Oct 2024. **URL:** https://doi.org/10.1371/journal.ppat.1012451 (wale2024amasterregulator pages 1-2)

### 5.2 Commensal-to-pathogen diversification via acquisition of an additional T3SS (2024)
A 2024 *Infection and Immunity* study on *Providencia alcalifaciens* demonstrates a boundary-case relevant to the trait: acquisition of a **plasmid-encoded T3SS (T3SS1a)** contributed to **entry, vacuole lysis, and cytosolic proliferation** in host cells, while a chromosomal T3SS had distinct host-specific roles; authors propose that acquiring two T3SSs enabled **host range diversification** from insect virulence to opportunistic gastrointestinal pathogenicity. **Publication date:** Oct 2024. **URL:** https://doi.org/10.1128/iai.00314-24 (klein2024pathogenicdiversificationof pages 1-2)

### 5.3 Clinical genomics connecting virulence markers to severity (2024)
A 2024 *Communications Medicine* cohort analysis of **773 adult patients** with *Pseudomonas aeruginosa* bloodstream infection linked virulence genotype clusters to outcomes, reporting associations where **T3SS** correlates with **septic shock**, and **biofilm synthesis genes** correlate with **mortality**; addition of genomic biomarkers improved prediction of severe outcomes in ML models. For TraitMech, these are valuable as “clinical association” edges but should be curated with uncertainty if no direct causal perturbation is shown. **Publication date:** Dec 2024. **URL:** https://doi.org/10.1038/s43856-024-00696-4 (valik2024genomicvirulencemarkers pages 1-2)

### 5.4 QS/biofilm mechanistic consolidation and anti-virulence translation (2024)
Multiple 2024 reviews consolidate QS→virulence/biofilm control logic and translate it into intervention concepts (quorum quenching enzymes; QS inhibitors; device coatings). QS is described as globally regulating gene expression, with QS-dependent EPS/exopolysaccharide synthesis contributing to biofilm architecture and downstream antibiotic tolerance/immune evasion. **URLs:** https://doi.org/10.3390/antibiotics13070619 (Jul 2024) and https://doi.org/10.1016/j.tcsw.2024.100133 (Dec 2024). (d’aquila2024quorumquenchingapproaches pages 1-2, mitra2024combattingbiofilmmediatedinfections pages 1-2)

## 6) Current applications and real-world implementations

### 6.1 Anti-biofilm and anti-virulence strategies (QS targeting)
Real-world implementation themes include using **QS inhibitors (QSIs)** and **quorum-quenching enzymes (QQ)** to reduce pathogenic biofilm formation and virulence without bactericidal selection pressure. Reviews report incorporation of quorum-sensing inhibition approaches into **medical devices** (e.g., **dressings and catheters**) as preventive strategies against biofilm infections. **Publication date:** Aug 2024. **URL:** https://doi.org/10.1007/s10096-024-04920-w (naga2024aninsighton pages 1-4)

### 6.2 Clinical risk stratification and prognostics using virulence genotypes
In invasive infections, genomic virulence markers can provide **prognostic information** (e.g., T3SS or biofilm gene signatures) and improve predictive models for outcomes like septic shock and mortality, potentially guiding adjunctive therapy decisions. This is a real-world direction for pathogen genomics in clinical microbiology. **Publication date:** Dec 2024. **URL:** https://doi.org/10.1038/s43856-024-00696-4 (valik2024genomicvirulencemarkers pages 1-2)

## 7) Relevant statistics and data (recent sources)

### 7.1 Biofilm burden in infections
* A 2024 review cites NIH estimates that **~65% of microbial infections** and **~80% of chronic infections** are associated with biofilm formation. **Publication date:** Jul 2024. **URL:** https://doi.org/10.3390/antibiotics13070619 (d’aquila2024quorumquenchingapproaches pages 1-2)
* Biofilm growth can confer large increases in antibiotic tolerance; one 2024 review summarizes that **biofilm bacteria increase antibiotic resistance by ~1000-fold**. **Publication date:** Feb 2024. **URL:** https://doi.org/10.3390/ijms25052655 (juszczukkubiak2024molecularaspectsof pages 2-3)

### 7.2 Device-associated infection proportions (clinical context)
A 2024 systematic review reports substantial biofilm involvement in device infections, including estimates such as **40–50%** of prosthetic heart valve infections and **50–70%** of catheter biofilm infections attributed to staphylococci, and high proportions of bloodstream infection links in its synthesis; it also reports catheter infection risk rising **~10% per day** a catheter remains in situ (reported as part of the review’s collated clinical statistics). **Publication date:** Jun 2024. **URL:** https://doi.org/10.3390/bacteria3030008 (erkihun2024medicalscopeof pages 2-4)

### 7.3 Cohort size for virulence–outcome associations
The 2024 *Communications Medicine* study analyzed **773 adult patients** with *P. aeruginosa* bloodstream infection, providing a large real-world dataset for relating virulence genotypes to outcomes. **Publication date:** Dec 2024. **URL:** https://doi.org/10.1038/s43856-024-00696-4 (valik2024genomicvirulencemarkers pages 1-2)

## 8) Expert analysis / curation guidance (what is strong enough to curate)

### Strongly curatable (mechanism demonstrated or broadly conserved)
* **T3SS → effector delivery → host process manipulation** as a core pathogenic mechanism (generalizable across many Gram-negatives; may require “bacterial T3SS” node plus taxon-specific implementations). (pandey2024bacterialpathogenesis pages 17-19)
* **Adhesin/surface-protein sequence variation → host receptor binding changes → host tropism shifts** (key for ecology/host adaptation). (barber2024mechanismsofhost pages 1-2)
* **Complement evasion via complement regulator recruitment or complement convertase inhibition** as mechanistic immune evasion strategies (though exact proteins vary). (barber2024mechanismsofhost pages 8-10)
* **QS → global virulence gene regulation** and **QS → EPS/biofilm maturation → antibiotic tolerance/immune evasion** (supported across multiple 2024 syntheses). (d’aquila2024quorumquenchingapproaches pages 1-2, juszczukkubiak2024molecularaspectsof pages 2-3, mitra2024combattingbiofilmmediatedinfections pages 1-2)

### Curate with “taxon-specific” qualifiers
* Specific effectors/regulators such as **PdhR→LEE activation** (attaching/effacing pathogens) and **Providencia T3SS1a-mediated entry/vacuole lysis** (strong evidence but not universal). (wale2024amasterregulator pages 1-2, klein2024pathogenicdiversificationof pages 1-2)
* Specific immune evasion proteins (CHIPS/SCIN/SpA) as exemplars rather than universal nodes. (barber2024mechanismsofhost pages 8-10)

### Curate with “association-only / uncertain causality” flags
* Clinical genotype-outcome links (e.g., “T3SS associated with septic shock” in bloodstream infection cohorts) are important for applied risk models but may not satisfy a strict causal-perturbation bar without experimental validation. (valik2024genomicvirulencemarkers pages 1-2)

## 9) Warnings (claims that should not yet be curated into TraitMech)
1. **Over-generalizing species-specific factors** (e.g., SpA, CHIPS, SCIN; specific toxin/receptor glycan compatibilities) to all pathogens without taxon constraints risks incorrect universal edges. (barber2024mechanismsofhost pages 8-10)
2. **Clinical association ≠ causation**: outcome correlations from cohort genomics should be curated as association edges or flagged uncertain unless supported by functional experiments. (valik2024genomicvirulencemarkers pages 1-2)
3. **Biofilm prevalence statistics** (NIH estimates, hospital fractions) are widely cited but should be treated as **contextual epidemiology**, not as direct mechanistic edges. (d’aquila2024quorumquenchingapproaches pages 1-2, erkihun2024medicalscopeof pages 2-4)

## 10) DOI-first bibliography (with dates/URLs where available)
* Barber MF, Fitzgerald JR. **Mechanisms of host adaptation by bacterial pathogens.** *FEMS Microbiology Reviews.* **Jul 2024.** DOI: **10.1093/femsre/fuae019**. URL: https://doi.org/10.1093/femsre/fuae019 (barber2024mechanismsofhost pages 1-2, barber2024mechanismsofhost pages 8-10)
* Wale KR, O’Boyle N, McHugh RE, et al. **A master regulator of central carbon metabolism directly activates virulence gene expression in attaching and effacing pathogens.** *PLOS Pathogens.* **Oct 2024.** DOI: **10.1371/journal.ppat.1012451**. URL: https://doi.org/10.1371/journal.ppat.1012451 (wale2024amasterregulator pages 1-2)
* Klein JA, Predeus AV, Greissl AR, et al. **Pathogenic diversification of the gut commensal Providencia alcalifaciens via acquisition of a second type III secretion system.** *Infection and Immunity.* **Oct 2024.** DOI: **10.1128/iai.00314-24**. URL: https://doi.org/10.1128/iai.00314-24 (klein2024pathogenicdiversificationof pages 1-2)
* Valik JKK, Giske CG, Hasan B, et al. **Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection.** *Communications Medicine.* **Dec 2024.** DOI: **10.1038/s43856-024-00696-4**. URL: https://doi.org/10.1038/s43856-024-00696-4 (valik2024genomicvirulencemarkers pages 1-2)
* D’Aquila P, De Rose E, Sena G, et al. **Quorum quenching approaches against bacterial-biofilm-induced antibiotic resistance.** *Antibiotics.* **Jul 2024.** DOI: **10.3390/antibiotics13070619**. URL: https://doi.org/10.3390/antibiotics13070619 (d’aquila2024quorumquenchingapproaches pages 1-2)
* Juszczuk-Kubiak E. **Molecular aspects of the functioning of pathogenic bacteria biofilm based on quorum sensing (QS) signal-response system and innovative non-antibiotic strategies for their elimination.** *International Journal of Molecular Sciences.* **Feb 2024.** DOI: **10.3390/ijms25052655**. URL: https://doi.org/10.3390/ijms25052655 (juszczukkubiak2024molecularaspectsof pages 2-3, juszczukkubiak2024molecularaspectsof pages 8-9)
* Naga NG, Shaaban MI, El-Metwally MM. **An insight on the powerful of bacterial quorum sensing inhibition.** *European Journal of Clinical Microbiology & Infectious Diseases.* **Aug 2024.** DOI: **10.1007/s10096-024-04920-w**. URL: https://doi.org/10.1007/s10096-024-04920-w (naga2024aninsighton pages 1-4)
* Mitra A. **Combatting biofilm-mediated infections in clinical settings by targeting quorum sensing.** *The Cell Surface.* **Dec 2024.** DOI: **10.1016/j.tcsw.2024.100133**. URL: https://doi.org/10.1016/j.tcsw.2024.100133 (mitra2024combattingbiofilmmediatedinfections pages 1-2)
* Erkihun M, Asmare Z, Endalamew K, et al. **Medical scope of biofilm and quorum sensing during biofilm formation: systematic review.** *Bacteria.* **Jun 2024.** DOI: **10.3390/bacteria3030008**. URL: https://doi.org/10.3390/bacteria3030008 (erkihun2024medicalscopeof pages 2-4, erkihun2024medicalscopeof pages 1-2)
* Pandey N. **BACTERIAL PATHOGENESIS.** In: *Microbes of Medical Importance.* **Aug 2024.** DOI: **10.58532/nbennurmmch1**. URL: https://doi.org/10.58532/nbennurmmch1 (pandey2024bacterialpathogenesis pages 17-19, pandey2024bacterialpathogenesis pages 10-13, pandey2024bacterialpathogenesis pages 8-10)

References

1. (barber2024mechanismsofhost pages 1-2): Matthew F Barber and J Ross Fitzgerald. Mechanisms of host adaptation by bacterial pathogens. FEMS Microbiology Reviews, Jul 2024. URL: https://doi.org/10.1093/femsre/fuae019, doi:10.1093/femsre/fuae019. This article has 46 citations and is from a domain leading peer-reviewed journal.

2. (barber2024mechanismsofhost pages 8-10): Matthew F Barber and J Ross Fitzgerald. Mechanisms of host adaptation by bacterial pathogens. FEMS Microbiology Reviews, Jul 2024. URL: https://doi.org/10.1093/femsre/fuae019, doi:10.1093/femsre/fuae019. This article has 46 citations and is from a domain leading peer-reviewed journal.

3. (klein2024pathogenicdiversificationof pages 1-2): Jessica A. Klein, Alexander V. Predeus, Aimee R. Greissl, Mattie M. Clark-Herrera, Eddy Cruz, Jennifer A. Cundiff, Amanda L. Haeberle, Maya Howell, Aaditi Lele, Donna J. Robinson, Trina L. Westerman, Marie Wrande, Sarah J. Wright, Nicole M. Green, Bruce A. Vallance, Michael McClelland, Andres Mejia, Alan G. Goodman, Johanna R. Elfenbein, and Leigh A. Knodler. Pathogenic diversification of the gut commensal <i>providencia alcalifaciens</i> via acquisition of a second type iii secretion system. Oct 2024. URL: https://doi.org/10.1128/iai.00314-24, doi:10.1128/iai.00314-24. This article has 14 citations and is from a peer-reviewed journal.

4. (pandey2024bacterialpathogenesis pages 8-10): Neha Pandey. BACTERIAL PATHOGENESIS, pages 3-28. Iterative International Publishers, Selfypage Developers Pvt Ltd, Aug 2024. URL: https://doi.org/10.58532/nbennurmmch1, doi:10.58532/nbennurmmch1. This article has 3 citations.

5. (pandey2024bacterialpathogenesis pages 17-19): Neha Pandey. BACTERIAL PATHOGENESIS, pages 3-28. Iterative International Publishers, Selfypage Developers Pvt Ltd, Aug 2024. URL: https://doi.org/10.58532/nbennurmmch1, doi:10.58532/nbennurmmch1. This article has 3 citations.

6. (d’aquila2024quorumquenchingapproaches pages 1-2): Patrizia D’Aquila, Elisabetta De Rose, Giada Sena, Angelo Scorza, Bonaventura Cretella, Giuseppe Passarino, and Dina Bellizzi. Quorum quenching approaches against bacterial-biofilm-induced antibiotic resistance. Antibiotics, 13:619, Jul 2024. URL: https://doi.org/10.3390/antibiotics13070619, doi:10.3390/antibiotics13070619. This article has 38 citations.

7. (juszczukkubiak2024molecularaspectsof pages 2-3): Edyta Juszczuk-Kubiak. Molecular aspects of the functioning of pathogenic bacteria biofilm based on quorum sensing (qs) signal-response system and innovative non-antibiotic strategies for their elimination. International Journal of Molecular Sciences, 25:2655, Feb 2024. URL: https://doi.org/10.3390/ijms25052655, doi:10.3390/ijms25052655. This article has 138 citations.

8. (mitra2024combattingbiofilmmediatedinfections pages 1-2): Arindam Mitra. Combatting biofilm-mediated infections in clinical settings by targeting quorum sensing. Dec 2024. URL: https://doi.org/10.1016/j.tcsw.2024.100133, doi:10.1016/j.tcsw.2024.100133. This article has 49 citations.

9. (wale2024amasterregulator pages 1-2): Kabo R. Wale, Nicky O’Boyle, Rebecca E. McHugh, Ester Serrano, David R. Mark, Gillian R. Douce, James P. R. Connolly, and Andrew J. Roe. A master regulator of central carbon metabolism directly activates virulence gene expression in attaching and effacing pathogens. Oct 2024. URL: https://doi.org/10.1371/journal.ppat.1012451, doi:10.1371/journal.ppat.1012451. This article has 11 citations and is from a highest quality peer-reviewed journal.

10. (erkihun2024medicalscopeof pages 1-2): Mulat Erkihun, Zelalem Asmare, Kirubel Endalamew, Birhanu Getie, Teklehayimanot Kiros, and Ayenew Berhan. Medical scope of biofilm and quorum sensing during biofilm formation: systematic review. Bacteria, 3:118-135, Jun 2024. URL: https://doi.org/10.3390/bacteria3030008, doi:10.3390/bacteria3030008. This article has 52 citations.

11. (valik2024genomicvirulencemarkers pages 1-2): John Karlsson Valik, Christian G. Giske, Badrul Hasan, Mónica Gozalo-Margüello, Luis Martínez-Martínez, Manica Mueller Premru, Žiga Martinčič, Bojana Beović, Sofia Maraki, Maria Zacharioudaki, Diamantis Kofteridis, Kate McCarthy, David Paterson, Marina de Cueto, Isabel Morales, Leonard Leibovici, Tanya Babich, Fredrik Granath, Jesús Rodríguez-Baño, Antonio Oliver, Dafna Yahav, and Pontus Nauclér. Genomic virulence markers are associated with severe outcomes in patients with pseudomonas aeruginosa bloodstream infection. Communications Medicine, Dec 2024. URL: https://doi.org/10.1038/s43856-024-00696-4, doi:10.1038/s43856-024-00696-4. This article has 12 citations and is from a peer-reviewed journal.

12. (pandey2024bacterialpathogenesis pages 10-13): Neha Pandey. BACTERIAL PATHOGENESIS, pages 3-28. Iterative International Publishers, Selfypage Developers Pvt Ltd, Aug 2024. URL: https://doi.org/10.58532/nbennurmmch1, doi:10.58532/nbennurmmch1. This article has 3 citations.

13. (naga2024aninsighton pages 1-4): Nourhan G. Naga, Mona I. Shaaban, and Mohammad Magdy El-Metwally. An insight on the powerful of bacterial quorum sensing inhibition. European Journal of Clinical Microbiology & Infectious Diseases, 43:2071-2081, Aug 2024. URL: https://doi.org/10.1007/s10096-024-04920-w, doi:10.1007/s10096-024-04920-w. This article has 41 citations and is from a peer-reviewed journal.

14. (erkihun2024medicalscopeof pages 2-4): Mulat Erkihun, Zelalem Asmare, Kirubel Endalamew, Birhanu Getie, Teklehayimanot Kiros, and Ayenew Berhan. Medical scope of biofilm and quorum sensing during biofilm formation: systematic review. Bacteria, 3:118-135, Jun 2024. URL: https://doi.org/10.3390/bacteria3030008, doi:10.3390/bacteria3030008. This article has 52 citations.

15. (juszczukkubiak2024molecularaspectsof pages 8-9): Edyta Juszczuk-Kubiak. Molecular aspects of the functioning of pathogenic bacteria biofilm based on quorum sensing (qs) signal-response system and innovative non-antibiotic strategies for their elimination. International Journal of Molecular Sciences, 25:2655, Feb 2024. URL: https://doi.org/10.3390/ijms25052655, doi:10.3390/ijms25052655. This article has 138 citations.